Wang Xiangming, Wang Xiaoyan, Gao Huili, Wang Danqiao
Medical Experimental Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhongguo Zhong Yao Za Zhi. 2010 Mar;35(5):661-3.
Parkinson's disease (PD) is a neurodegenerative disorder with a complex, multifactorial aetiology. The brains of patients affected with PD are characterized by a loss of neurons in dopamine neurons in the substantia nigra, decreasing of dopamine secretion, and the deposition of Lewy bodies (LBs) in the cytoplasm of remaining neurons. In China the data show that the incidence of Parkinson's disease increases at least 20 times in recent 20 years, and it makes things worse for the aging society. Developing good anti-PD drugs to improve the patient's quality of life is particularly important. The treatment of PD using traditional Chinese medicine (TCM) has made remarkable effect, while the the molecular mechanisms of it is still not known, while elucidating the molecular mechanism of TCM is the base of better understanding its function. Using genetically modified PD model of Caenorhabditis elegans, which is suitable for molecular mechanism study, to explore the interference mechanism of TCM to PD might be an effective way. This review briefly introduces the research progress on molecular mechanism of PD, and then discusses the idea of using C. elegans to study molecular mechanism of TCM intervention to PD.
帕金森病(PD)是一种病因复杂、具有多因素的神经退行性疾病。帕金森病患者的大脑特征为黑质中多巴胺能神经元丧失、多巴胺分泌减少以及路易小体(LBs)在剩余神经元的细胞质中沉积。中国的数据显示,帕金森病的发病率在最近20年至少增加了20倍,这对老龄化社会来说更是雪上加霜。研发有效的抗帕金森病药物以提高患者的生活质量尤为重要。中医药治疗帕金森病已取得显著疗效,但其分子机制仍不清楚,而阐明中医药的分子机制是更好理解其作用的基础。利用适合分子机制研究的转基因秀丽隐杆线虫帕金森病模型来探索中医药对帕金森病的干预机制可能是一种有效方法。本文综述简要介绍了帕金森病分子机制的研究进展,然后探讨了利用秀丽隐杆线虫研究中医药干预帕金森病分子机制的思路。